EDISON, N.J.--(BUSINESS WIRE)--I-many, Inc. (NASDAQ:IMNY), the leading provider of advanced Contract Lifecycle Management (CLM) solutions for managing corporate commitments, today announced that AVANIR Pharmaceuticals, a provider of therapeutic products for treating chronic diseases, has licensed I-many’s CLM solution for Life Sciences to manage their Medicaid and managed care rebate processes. AVANIR’s license of I-many Medicaid, I-many CARS, and I-many Validata will enable the company to cost-effectively and accurately manage the complexities of Medicaid and managed care contracts associated with its currently marketed drug.
